Annual Net Income
-$615.06 M
-$1.13 B-219.24%
December 31, 2023
Summary
- As of February 7, 2025, VIR annual net profit is -$615.06 million, with the most recent change of -$1.13 billion (-219.24%) on December 31, 2023.
- During the last 3 years, VIR annual net income has fallen by -$316.40 million (-105.94%).
- VIR annual net income is now -216.36% below its all-time high of $528.58 million, reached on December 31, 2021.
Performance
VIR Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Net Income
-$213.72 M
-$75.34 M-54.44%
September 30, 2024
Summary
- As of February 7, 2025, VIR quarterly net profit is -$213.72 million, with the most recent change of -$75.34 million (-54.44%) on September 30, 2024.
- Over the past year, VIR quarterly net income has dropped by -$75.34 million (-54.44%).
- VIR quarterly net income is now -140.69% below its all-time high of $525.25 million, reached on December 31, 2021.
Performance
VIR Quarterly Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM Net Income
-$533.34 M
-$50.30 M-10.41%
September 30, 2024
Summary
- As of February 7, 2025, VIR TTM net profit is -$533.34 million, with the most recent change of -$50.30 million (-10.41%) on September 30, 2024.
- Over the past year, VIR TTM net income has dropped by -$50.30 million (-10.41%).
- VIR TTM net income is now -143.86% below its all-time high of $1.22 billion, reached on March 31, 2022.
Performance
VIR TTM Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Net Income Formula
Net Income = Revenue − COGS − Operating Expenses − Interest − Taxes − Other Expenses
VIR Net Income Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -219.2% | -54.4% | -10.4% |
| 3 y3 years | -105.9% | -51.7% | -271.2% |
| 5 y5 years | -430.8% | -51.7% | -271.2% |
VIR Net Income Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -216.4% | at low | -140.7% | at low | -143.9% | +13.3% |
| 5 y | 5-year | -216.4% | at low | -140.7% | at low | -143.9% | +13.3% |
| alltime | all time | -216.4% | at low | -140.7% | at low | -143.9% | +13.3% |
Vir Biotechnology Net Income History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$213.72 M(+54.4%) | -$533.34 M(+10.4%) |
| Jun 2024 | - | -$138.38 M(+112.0%) | -$483.04 M(-10.5%) |
| Mar 2024 | - | -$65.28 M(-43.7%) | -$539.44 M(-12.3%) |
| Dec 2023 | -$615.06 M(-219.2%) | -$115.97 M(-29.0%) | -$615.06 M(+2.4%) |
| Sep 2023 | - | -$163.41 M(-16.1%) | -$600.69 M(+129.3%) |
| Jun 2023 | - | -$194.78 M(+38.2%) | -$261.97 M(+82.3%) |
| Mar 2023 | - | -$140.90 M(+38.7%) | -$143.68 M(-127.9%) |
| Dec 2022 | $515.84 M(-2.4%) | -$101.60 M(-158.0%) | $515.84 M(-54.9%) |
| Sep 2022 | - | $175.31 M(-329.2%) | $1.14 B(+6.0%) |
| Jun 2022 | - | -$76.49 M(-114.7%) | $1.08 B(-11.4%) |
| Mar 2022 | - | $518.62 M(-1.3%) | $1.22 B(+130.1%) |
| Dec 2021 | $528.58 M | $525.25 M(+375.7%) | $528.58 M(-616.6%) |
| Sep 2021 | - | $110.43 M(+78.6%) | -$102.32 M(-65.6%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2021 | - | $61.81 M(-136.6%) | -$297.36 M(-23.8%) |
| Mar 2021 | - | -$168.91 M(+59.9%) | -$390.34 M(+30.7%) |
| Dec 2020 | -$298.67 M(+71.0%) | -$105.65 M(+24.9%) | -$298.67 M(+16.3%) |
| Sep 2020 | - | -$84.61 M(+171.5%) | -$256.79 M(+16.5%) |
| Jun 2020 | - | -$31.17 M(-59.6%) | -$220.49 M(-1.2%) |
| Mar 2020 | - | -$77.24 M(+21.1%) | -$223.25 M(+27.8%) |
| Dec 2019 | -$174.68 M(+50.7%) | -$63.77 M(+32.0%) | -$174.68 M(+27.2%) |
| Sep 2019 | - | -$48.31 M(+42.4%) | -$137.31 M(+12.1%) |
| Jun 2019 | - | -$33.93 M(+18.3%) | -$122.45 M(+38.3%) |
| Mar 2019 | - | -$28.67 M(+8.6%) | -$88.52 M(+47.9%) |
| Dec 2018 | -$115.88 M(+65.9%) | -$26.39 M(-21.1%) | -$59.85 M(+78.9%) |
| Sep 2018 | - | -$33.46 M | -$33.46 M |
| Dec 2017 | -$69.85 M | - | - |
FAQ
- What is Vir Biotechnology annual net profit?
- What is the all time high annual net income for Vir Biotechnology?
- What is Vir Biotechnology annual net income year-on-year change?
- What is Vir Biotechnology quarterly net profit?
- What is the all time high quarterly net income for Vir Biotechnology?
- What is Vir Biotechnology quarterly net income year-on-year change?
- What is Vir Biotechnology TTM net profit?
- What is the all time high TTM net income for Vir Biotechnology?
- What is Vir Biotechnology TTM net income year-on-year change?
What is Vir Biotechnology annual net profit?
The current annual net income of VIR is -$615.06 M
What is the all time high annual net income for Vir Biotechnology?
Vir Biotechnology all-time high annual net profit is $528.58 M
What is Vir Biotechnology annual net income year-on-year change?
Over the past year, VIR annual net profit has changed by -$1.13 B (-219.24%)
What is Vir Biotechnology quarterly net profit?
The current quarterly net income of VIR is -$213.72 M
What is the all time high quarterly net income for Vir Biotechnology?
Vir Biotechnology all-time high quarterly net profit is $525.25 M
What is Vir Biotechnology quarterly net income year-on-year change?
Over the past year, VIR quarterly net profit has changed by -$75.34 M (-54.44%)
What is Vir Biotechnology TTM net profit?
The current TTM net income of VIR is -$533.34 M
What is the all time high TTM net income for Vir Biotechnology?
Vir Biotechnology all-time high TTM net profit is $1.22 B
What is Vir Biotechnology TTM net income year-on-year change?
Over the past year, VIR TTM net profit has changed by -$50.30 M (-10.41%)